These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6271048)

  • 1. Activity of moxalactam and cefotaxime alone and in combination with ampicillin or penicillin against group B streptococci.
    Landesman SH; Corrado ML; Cherubin CE; Sierra MF
    Antimicrob Agents Chemother; 1981 May; 19(5):794-7. PubMed ID: 6271048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.
    Schaad UB; McCracken GH; Loock CA; Thomas ML
    J Infect Dis; 1981 Feb; 143(2):156-63. PubMed ID: 6260870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of cefotaxime and ceftriaxone alone and in combination with penicillin, ampicillin and piperacillin against neonatal meningitis pathogens.
    Hoogkamp-Korstanje JA
    J Antimicrob Chemother; 1985 Sep; 16(3):327-34. PubMed ID: 3932295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
    Mintz L; Drew WL
    Antimicrob Agents Chemother; 1981 Feb; 19(2):332-4. PubMed ID: 6289731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibacterial activity of lamoxactam in combination with penicillin, ampicillin and amoxicillin against clinical strains of Enterococci, group B Streptococci and Listeria].
    Fosse T; Leclercq R; Rifai R; Toga B; Tamalet C; Soussy CJ; Duval J
    Pathol Biol (Paris); 1984 May; 32(5):372-4. PubMed ID: 6377205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae.
    Jorgensen JH; Crawford SA; Alexander GA
    Antimicrob Agents Chemother; 1980 Mar; 17(3):516-7. PubMed ID: 6252832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, and N-formimidoyl thienamycin.
    Cherubin CE; Corrado ML; Sierra MF; Gombert ME; Shulman M
    Antimicrob Agents Chemother; 1981 Oct; 20(4):553-5. PubMed ID: 6282200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative activity of cefotaxime and selected beta-lactam antibiotics against Haemophilus influenzae and aerobic gram-negative bacilli.
    Dabernat HJ; Delmas C
    Rev Infect Dis; 1982; 4 Suppl():S401-5. PubMed ID: 6294790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy between penicillins and low concentrations of gentamicin in the killing of group B streptococci.
    Swingle HM; Bucciarelli RL; Ayoub EM
    J Infect Dis; 1985 Sep; 152(3):515-20. PubMed ID: 3897398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of moxalactam alone and in combination with penicillin against common meningeal pathogens.
    Azimi PH; Dunphy MG
    Antimicrob Agents Chemother; 1982 Mar; 21(3):521-4. PubMed ID: 6213193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro bactericidal activity of cefonicid, ceftizoxime, and penicillin against group B streptococci.
    Bayer AS; Morrison JO; Kim KS
    Antimicrob Agents Chemother; 1982 Feb; 21(2):344-6. PubMed ID: 6280602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro activity of combinations of cefotaxime and moxalactam with aminoglycosides on beta-lactamase-producing Enterobacteriaceae].
    Sirot J; Sirot D; Garnier R; Joly B; Cluzel R
    Pathol Biol (Paris); 1983 Jun; 31(6):480-2. PubMed ID: 6308542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic-killing kinetics of group B streptococci.
    Schauf V; Deveikis A; Riff L; Serota A
    J Pediatr; 1976 Aug; 89(2):194-8. PubMed ID: 781200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
    Baumgärtner M; Dickgiesser N; Müller S; Wundt W
    Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillin.
    Tarpay MM; Welch DF; Marks MI
    Chemotherapy; 1982; 28(4):261-6. PubMed ID: 6214382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the in vitro activity of new cephalosporins on strains of Neisseria gonorrhoeae of the Toulouse region.
    Prère MF; Lefèvre JC; Lareng MB
    Chemotherapy; 1981; 27 Suppl 1():15-8. PubMed ID: 6265158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Pseudomonas aeruginosa to cefoperazone, cefotaxime and moxalactam, with special reference to isolates resistant to aminoglycosides, carbenicillin and ticarcillin.
    Woolfrey BF; Fox JM; Quall CO
    J Antimicrob Chemother; 1981 Sep; 8(3):205-11. PubMed ID: 6270052
    [No Abstract]   [Full Text] [Related]  

  • 19. In-vitro activity of the novel oxa-beta-lactam antibiotic moxalactam (LY 127935) against dense populations of selected Gram-negative bacilli.
    Greenwood D; Eley A; Pearson N; O'Grady F
    J Antimicrob Chemother; 1981 Apr; 7(4):353-62. PubMed ID: 6265424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
    Miller MA; LeFrock JL; Vercler MJ
    Microbiol Immunol; 1981; 25(11):1119-27. PubMed ID: 6276701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.